Feedback / Questions
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
FYB202 (ustekinumab biosimilar) - Formycon, Fresenius Kabi
https://www.pharmiweb.com/press-release/2023-11-13/formycon-publishes-nine-month-results-for-2023
Nov 13, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next